This research service outlines the technologies on influenza therapeutics.

Table Of Contents

Table of Contents

1 | EXECUTIVE SUMMARY

Industry Overview and Key Research Highlights
1. Industry Overview
2. Key Research Highlights

Scope and Methodology
1. Scope
2. Methodology

2 | GLOBAL RandD NETWORK ANALYSIS

Value Chain Analysis
1. Existing RandD Networks
2. Stakeholders RandD Focus

Environmental Assessment
1. Key Technology Drivers
2. Key Technology Challenges
3. Analysis of the Business Environment--Porter's Analysis
4. Analysis of the Internal Environment--SWOT Analysis

3 | STRATEGIC MANAGEMENT OF RandD

Industry Trends and Requirements
1. Current Industry and Research Trends
2. Technical Resource Competency
3. RandD Intensity
4. Availability of Funding and Future Milestones

RandD Management Strategy
1. Technology Strategy
2. RandD Strategy

New Product Development and Commercialization Strategy
1. Innovation Strategy
2. Intellectual Property (IP) Protection Strategy
3. Conclusion

4 | PATENTS AND KEY CONTACTS

Patents
1. Issued Patents across Industry and Academia
2. Applied Patents across Industries and Academia

Key Participants
1. Participants across Industry
2. Participants across Academia

5 | DECISION SUPPORT DATABASE

DSD Tables
1. Incidence of Haemophilus Influenzae--USA (2004 to 2014)
2. Government Investment in Biotech RandD (Million USD)--World (2004 to 2014)
3. Pharma RandD Expenditure (Million USD)--World (2004 to 2014)
4. Pharmaceutical Market (Billion USD)--World (2004 to 2014)

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Therapeutics for Women%s Health: Technologies and Global Markets

Therapeutics for Women%s Health: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • May 2014
  • by BCC Research

Use this report to: - Learn about the main women's health disorders and relevant disease prevalence population. - Identify the impact of demographic, economic, and other factors that will drive future ...

Chronic Lymphocytic Leukaemia: KOL Insight

Chronic Lymphocytic Leukaemia: KOL Insight

  • $ 5 369
  • Industry report
  • May 2014
  • by Firstword Pharma

Chronic lymphocytic leukaemia (CLL) is the most common of the leukaemias, but until recently it has been underserved in terms of effective therapeutic options. However, a revolution in personalised and ...

ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations

ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations

  • $ 4 995
  • Industry report
  • July 2014
  • by GBI Research

ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations Summary GBI Research has released the pharma report, “ADHD Therapeutics ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.